Cord Blood Preservation
Anthrogenesis Corp. announces license agreement
Published in Blood Weekly, January 9th, 2003
PharmaStem is the successor to Biocyte Corp., the pioneer in the development of umbilical cord and placental blood preservation and its therapeutic use.
John R. Haines, president and CEO of Anthrogenesis, stated: "We are very pleased about this license agreement with PharmaStem. Importantly, parents who entrust their children's cord blood to our Lifebank division can be secure in the knowledge that we are the first company to obtain a license under the important...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-01-09)
More Articles from Blood Weekly
- Bone Marrow Transplantation
Transduction with Fas ligand improves bone marrow engraftment - Stem Cell Transplantation
Peripheral blood stem cell grafts may be linked to lower quality of life - Cell Transplantation
Myeloablation enhances engraftment of transduced murine hematopoietic cells - Peripheral Blood Stem Cell Transplantation
Reduced DMSO levels in peripheral blood concentrate improves cell viability - Stem Cell Transplantation
Granulocyte colony-stimulating factor can hasten pediatric recovery - Stem Cell Transplantation
Human leukocyte antigen alleles affect graft-versus-host disease risk - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
